ADAM10 Sheddase Activity is a Potential Lung-Cancer Biomarker
Background: Increases in expression of ADAM10 and ADAM17 genes and proteins are inconsistently found in cancer lesions, and are not validated as clinically useful biomarkers. The enzyme-specific proteolytic activities, which are solely mediated by the active mature enzymes, directly reflect enzyme c...
Similar Items
-
Modification of proteolytic activity matrix analysis (PrAMA) to measure ADAM10 and ADAM17 sheddase activities in cell and tissue lysates
by: Yoneyama, Toshie, et al.
Published: (2018) -
ADAMs as EGFR ligand sheddases in prostate cancer
by: Willems, Sofie Henriëtte
Published: (2011) -
Phosphatidylserine exposure is required for ADAM17 sheddase function
by: Anselm Sommer, et al.
Published: (2016-05-01) -
Identification of ADAM12 as a Novel Basigin Sheddase
by: Reidar Albrechtsen, et al.
Published: (2019-04-01) -
Understanding and targeting network-level sheddase regulation in invasive disease
by: Miller, Miles Aaron
Published: (2013)